Vitamin K Antagonists vs Rivaroxaban in Hemodialysis Patients With Atrial Fibrillation
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of the American Society of Nephrology: JASN
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Safety and Efficacy of Vitamin K Antagonists Versus Rivaroxaban in Hemodialysis Patients With Atrial Fibrillation: A Multicenter Randomized Controlled Trial
J. Am. Soc. Nephrol. 2021 Mar 22;[EPub Ahead of Print], AS De Vriese, R Caluwé, H Van Der Meersch, K De Boeck, D De BacquerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.